Meta-Analysis of NUDT15 Genetic Polymorphism on Thiopurine-Induced Myelosuppression in Asian Populations

Backgound: The high incidence of thiopurine-induced myelosuppression in Asians is known to be attributable to genetic variation in thiopurine metabolism. A quantitative synthesis to summarize the genetic association with thiopurine-induced myelosuppression in Asians was therefore conducted.Methods:...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Kanyarat Khaeso, Sariya Udayachalerm, Patcharee Komvilaisak, Su-on Chainansamit, Kunanya Suwannaying, Napat Laoaroon, Pitchayanan Kuwatjanakul, Nontaya Nakkam, Chonlaphat Sukasem, Apichaya Puangpetch, Wichittra Tassaneeyakul, Nathorn Chaiyakunapruk
Formato: article
Lenguaje:EN
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://doaj.org/article/0b802fac302c4255b3dc0f00f3ef8768
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:0b802fac302c4255b3dc0f00f3ef8768
record_format dspace
spelling oai:doaj.org-article:0b802fac302c4255b3dc0f00f3ef87682021-12-02T11:20:34ZMeta-Analysis of NUDT15 Genetic Polymorphism on Thiopurine-Induced Myelosuppression in Asian Populations1663-981210.3389/fphar.2021.784712https://doaj.org/article/0b802fac302c4255b3dc0f00f3ef87682021-12-01T00:00:00Zhttps://www.frontiersin.org/articles/10.3389/fphar.2021.784712/fullhttps://doaj.org/toc/1663-9812Backgound: The high incidence of thiopurine-induced myelosuppression in Asians is known to be attributable to genetic variation in thiopurine metabolism. A quantitative synthesis to summarize the genetic association with thiopurine-induced myelosuppression in Asians was therefore conducted.Methods: A Literature search was performed from January 2016 to May 2021 in the following databases: PubMed, Web of Science, and Embase and addition search included the studies from Zhang et al. Two reviewers independently extracted the following data: the author’s name, year of publication, ethnicity, drugs, diseases, genetic polymorphisms, onset, type of myelosuppression and results of Hardy-Weinberg equilibrium. The Newcastle-Ottawa Scale was used to assess the quality of the studies. The pooled odds ratios (OR) and 95% confidence intervals (CI) were calculated to evaluate the associations of NUDT15 and the risk of thiopurine-induced myelosuppression stratified by onset and type of myelosuppressive. Subgroup analysis by NUDT15 genetic polymorphisms was performed.Results: A total of 30 studies was included in this meta-analysis. The overall OR for the relationship between NUDT15 genetic polymorphisms and thiopurine-induced early onset of leukopenia and neutropenia in Asian populations were 11.43 (95% CI 7.11–18.35) and 16.35 (95% CI 10.20–26.22). Among NUDT15 polymorphisms, NUDT15*3 showed a significantly increased risk of early leukopenia (OR 15.31; 95% CI 9.65–24.27) and early neutropenia (OR 15.85; 95% CI 8.80–28.53). A significantly higher thiopurine-induced early neutropenic risk was also found for NUDT15*2 (OR 37.51; 95% CI 1.99–708.69). Whereas, NUDT15*5 and NUDT15*6 variants showed a lower risk of leukopenia.Conclusion: This study suggests that NUDT15*3 and NUDT15*2 are important genetic markers of thiopurine-induced early onset of myelotoxicity in Asians, therefore, early detection of these variants before initiating thiopurine therapy is necessary.Kanyarat KhaesoSariya UdayachalermPatcharee KomvilaisakSu-on ChainansamitKunanya SuwannayingNapat LaoaroonPitchayanan KuwatjanakulNontaya NakkamChonlaphat SukasemChonlaphat SukasemApichaya PuangpetchApichaya PuangpetchWichittra TassaneeyakulNathorn ChaiyakunaprukFrontiers Media S.A.articlenucleoside diphosphate–linked moiety X-type motif 15 (NUDT15)thiopurine drugshematotoxicitygenetic polymorphismprecision medicineMeta-analysisTherapeutics. PharmacologyRM1-950ENFrontiers in Pharmacology, Vol 12 (2021)
institution DOAJ
collection DOAJ
language EN
topic nucleoside diphosphate–linked moiety X-type motif 15 (NUDT15)
thiopurine drugs
hematotoxicity
genetic polymorphism
precision medicine
Meta-analysis
Therapeutics. Pharmacology
RM1-950
spellingShingle nucleoside diphosphate–linked moiety X-type motif 15 (NUDT15)
thiopurine drugs
hematotoxicity
genetic polymorphism
precision medicine
Meta-analysis
Therapeutics. Pharmacology
RM1-950
Kanyarat Khaeso
Sariya Udayachalerm
Patcharee Komvilaisak
Su-on Chainansamit
Kunanya Suwannaying
Napat Laoaroon
Pitchayanan Kuwatjanakul
Nontaya Nakkam
Chonlaphat Sukasem
Chonlaphat Sukasem
Apichaya Puangpetch
Apichaya Puangpetch
Wichittra Tassaneeyakul
Nathorn Chaiyakunapruk
Meta-Analysis of NUDT15 Genetic Polymorphism on Thiopurine-Induced Myelosuppression in Asian Populations
description Backgound: The high incidence of thiopurine-induced myelosuppression in Asians is known to be attributable to genetic variation in thiopurine metabolism. A quantitative synthesis to summarize the genetic association with thiopurine-induced myelosuppression in Asians was therefore conducted.Methods: A Literature search was performed from January 2016 to May 2021 in the following databases: PubMed, Web of Science, and Embase and addition search included the studies from Zhang et al. Two reviewers independently extracted the following data: the author’s name, year of publication, ethnicity, drugs, diseases, genetic polymorphisms, onset, type of myelosuppression and results of Hardy-Weinberg equilibrium. The Newcastle-Ottawa Scale was used to assess the quality of the studies. The pooled odds ratios (OR) and 95% confidence intervals (CI) were calculated to evaluate the associations of NUDT15 and the risk of thiopurine-induced myelosuppression stratified by onset and type of myelosuppressive. Subgroup analysis by NUDT15 genetic polymorphisms was performed.Results: A total of 30 studies was included in this meta-analysis. The overall OR for the relationship between NUDT15 genetic polymorphisms and thiopurine-induced early onset of leukopenia and neutropenia in Asian populations were 11.43 (95% CI 7.11–18.35) and 16.35 (95% CI 10.20–26.22). Among NUDT15 polymorphisms, NUDT15*3 showed a significantly increased risk of early leukopenia (OR 15.31; 95% CI 9.65–24.27) and early neutropenia (OR 15.85; 95% CI 8.80–28.53). A significantly higher thiopurine-induced early neutropenic risk was also found for NUDT15*2 (OR 37.51; 95% CI 1.99–708.69). Whereas, NUDT15*5 and NUDT15*6 variants showed a lower risk of leukopenia.Conclusion: This study suggests that NUDT15*3 and NUDT15*2 are important genetic markers of thiopurine-induced early onset of myelotoxicity in Asians, therefore, early detection of these variants before initiating thiopurine therapy is necessary.
format article
author Kanyarat Khaeso
Sariya Udayachalerm
Patcharee Komvilaisak
Su-on Chainansamit
Kunanya Suwannaying
Napat Laoaroon
Pitchayanan Kuwatjanakul
Nontaya Nakkam
Chonlaphat Sukasem
Chonlaphat Sukasem
Apichaya Puangpetch
Apichaya Puangpetch
Wichittra Tassaneeyakul
Nathorn Chaiyakunapruk
author_facet Kanyarat Khaeso
Sariya Udayachalerm
Patcharee Komvilaisak
Su-on Chainansamit
Kunanya Suwannaying
Napat Laoaroon
Pitchayanan Kuwatjanakul
Nontaya Nakkam
Chonlaphat Sukasem
Chonlaphat Sukasem
Apichaya Puangpetch
Apichaya Puangpetch
Wichittra Tassaneeyakul
Nathorn Chaiyakunapruk
author_sort Kanyarat Khaeso
title Meta-Analysis of NUDT15 Genetic Polymorphism on Thiopurine-Induced Myelosuppression in Asian Populations
title_short Meta-Analysis of NUDT15 Genetic Polymorphism on Thiopurine-Induced Myelosuppression in Asian Populations
title_full Meta-Analysis of NUDT15 Genetic Polymorphism on Thiopurine-Induced Myelosuppression in Asian Populations
title_fullStr Meta-Analysis of NUDT15 Genetic Polymorphism on Thiopurine-Induced Myelosuppression in Asian Populations
title_full_unstemmed Meta-Analysis of NUDT15 Genetic Polymorphism on Thiopurine-Induced Myelosuppression in Asian Populations
title_sort meta-analysis of nudt15 genetic polymorphism on thiopurine-induced myelosuppression in asian populations
publisher Frontiers Media S.A.
publishDate 2021
url https://doaj.org/article/0b802fac302c4255b3dc0f00f3ef8768
work_keys_str_mv AT kanyaratkhaeso metaanalysisofnudt15geneticpolymorphismonthiopurineinducedmyelosuppressioninasianpopulations
AT sariyaudayachalerm metaanalysisofnudt15geneticpolymorphismonthiopurineinducedmyelosuppressioninasianpopulations
AT patchareekomvilaisak metaanalysisofnudt15geneticpolymorphismonthiopurineinducedmyelosuppressioninasianpopulations
AT suonchainansamit metaanalysisofnudt15geneticpolymorphismonthiopurineinducedmyelosuppressioninasianpopulations
AT kunanyasuwannaying metaanalysisofnudt15geneticpolymorphismonthiopurineinducedmyelosuppressioninasianpopulations
AT napatlaoaroon metaanalysisofnudt15geneticpolymorphismonthiopurineinducedmyelosuppressioninasianpopulations
AT pitchayanankuwatjanakul metaanalysisofnudt15geneticpolymorphismonthiopurineinducedmyelosuppressioninasianpopulations
AT nontayanakkam metaanalysisofnudt15geneticpolymorphismonthiopurineinducedmyelosuppressioninasianpopulations
AT chonlaphatsukasem metaanalysisofnudt15geneticpolymorphismonthiopurineinducedmyelosuppressioninasianpopulations
AT chonlaphatsukasem metaanalysisofnudt15geneticpolymorphismonthiopurineinducedmyelosuppressioninasianpopulations
AT apichayapuangpetch metaanalysisofnudt15geneticpolymorphismonthiopurineinducedmyelosuppressioninasianpopulations
AT apichayapuangpetch metaanalysisofnudt15geneticpolymorphismonthiopurineinducedmyelosuppressioninasianpopulations
AT wichittratassaneeyakul metaanalysisofnudt15geneticpolymorphismonthiopurineinducedmyelosuppressioninasianpopulations
AT nathornchaiyakunapruk metaanalysisofnudt15geneticpolymorphismonthiopurineinducedmyelosuppressioninasianpopulations
_version_ 1718395978470391808